PremiumThe FlyPredictive Oncology issued shareholder letter Predictive Oncology Inc. Reports Q1 2025 Earnings Predictive Oncology reports Q1 EPS (34c) vs ($1.04) last year PremiumThe FlyRenovaro BioSciences provides update to agreement with Predictive Oncology Renovaro says Predictive Oncology terminated merger agreement Predictive Oncology Reports 2024 Financial Results and Merger Plans PremiumThe FlyPredictive Oncology moves to finalize merger agreement with Renovaro Predictive Oncology prices 363,336 shares at $1.50 in registered direct offering Predictive Oncology reports positive results using AI for drug repurposing 
